Affinity Investment Advisors, LLC Pacira Bio Sciences, Inc. Transaction History

Affinity Investment Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$26.32 - $34.31 $95,278 - $124,202	-3,620 Reduced 37.15%	6,125 $206,000
Q2 2023 Aug 10, 2023	SELL	$36.12 - $47.5 $70,975 - $93,337	-1,965 Reduced 16.78%	9,745 $390,000
Q4 2022 Feb 08, 2023	BUY	$38.19 - $57.45 $3,780 - $5,687	99 Added 0.85%	11,710 $452,000
Q2 2022 Jul 27, 2022	SELL	$51.49 - $81.64 $32,953 - $52,249	-640 Reduced 5.22%	11,611 $677,000
Q1 2022 May 05, 2022	SELL	$60.03 - $76.49 $203,201 - $258,918	-3,385 Reduced 21.65%	12,251 $935,000
Q4 2021 Feb 04, 2022	BUY	$47.97 - $62.21 $3,693 - $4,790	77 Added 0.49%	15,636 $941,000
Q1 2021 May 13, 2021	SELL	$59.31 - $78.82 $56,344 - $74,879	-950 Reduced 5.75%	15,559 $1.09 Million
Q4 2020 Feb 12, 2021	SELL	$50.47 - $66.26 $20,692 - $27,166	-410 Reduced 2.42%	16,509 $988,000
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $19,228 - $23,310	-370 Reduced 2.14%	16,919 $1.02 Million
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $158,188 - $282,399	5,570 Added 47.53%	17,289 $580,000
Q2 2019 Aug 08, 2019	BUY	$36.57 - $47.97 $428,563 - $562,160	11,719 New	11,719 $510,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Affinity Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Investment Advisors, LLC with notifications on news.